Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

TREX1 Mutation Causing Autosomal Dominant Thrombotic Microangiopathy and CKD-A Novel Presentation.

Gulati A, Bale AE, Dykas DJ, Bia MJ, Danovitch GM, Moeckel GW, Somlo S, Dahl NK.

Am J Kidney Dis. 2018 Dec;72(6):895-899. doi: 10.1053/j.ajkd.2018.05.006. Epub 2018 Jun 22.

PMID:
29941221
2.

Diarrhea in a Long-Term Kidney-Pancreas Recipient.

Bia MJ.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):998-1000. doi: 10.2215/CJN.12671216. Epub 2017 Mar 24. No abstract available.

3.

Slow Rise in Serum Creatinine Level in a Kidney Transplant Recipient 3 Years Post-Transplant.

Bia MJ.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1692-1694. doi: 10.2215/CJN.12691216. Epub 2017 Mar 23. No abstract available.

4.

New Organ Allocation System for Combined Liver-Kidney Transplants and the Availability of Kidneys for Transplant to Patients with Stage 4-5 CKD.

Asch WS, Bia MJ.

Clin J Am Soc Nephrol. 2017 May 8;12(5):848-852. doi: 10.2215/CJN.08480816. Epub 2016 Dec 27.

5.

Oncologic issues and kidney transplantation: a review of frequency, mortality, and screening.

Asch WS, Bia MJ.

Adv Chronic Kidney Dis. 2014 Jan;21(1):106-13. doi: 10.1053/j.ackd.2013.07.003. Review.

PMID:
24359993
6.

A one-day centralized work-up for kidney transplant recipient candidates: a quality improvement report.

Formica RN Jr, Barrantes F, Asch WS, Bia MJ, Coca S, Kalyesubula R, McCloskey B, Leary T, Arvelakis A, Kulkarni S.

Am J Kidney Dis. 2012 Aug;60(2):288-94. doi: 10.1053/j.ajkd.2012.04.008. Epub 2012 May 8.

PMID:
22571868
7.

Patient education to reduce disparities in renal transplantation.

Asch WS, Bia MJ.

Clin J Am Soc Nephrol. 2012 Apr;7(4):527-9. doi: 10.2215/CJN.01770212. Epub 2012 Mar 8. No abstract available.

8.

Should living kidney donor candidates with impaired fasting glucose donate?

Vigneault CB, Asch WS, Dahl NK, Bia MJ.

Clin J Am Soc Nephrol. 2011 Aug;6(8):2054-9. doi: 10.2215/CJN.03370411. Epub 2011 Jul 22. Review.

9.

Management of cardiovascular disease in renal transplant recipients.

Shirali AC, Bia MJ.

Clin J Am Soc Nephrol. 2008 Mar;3(2):491-504. doi: 10.2215/CJN.05081107. Epub 2008 Feb 20. Review.

10.

A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.

Formica RN Jr, Friedman AL, Lorber MI, Smith JD, Eisen T, Bia MJ.

Nephrol Dial Transplant. 2006 May;21(5):1389-94. Epub 2006 Jan 23.

PMID:
16431893
11.

Renal transplant recipients over aged 60 have diminished immune activity and a low risk of rejection.

Friedman AL, Goker O, Kalish MA, Basadonna GP, Kliger AS, Bia MJ, Lorber MI.

Int Urol Nephrol. 2004;36(3):451-6.

PMID:
15783123
12.
13.

The evolving experience using everolimus in clinical transplantation.

Formica RN Jr, Lorber KM, Friedman AL, Bia MJ, Lakkis F, Smith JD, Lorber MI.

Transplant Proc. 2004 Mar;36(2 Suppl):495S-499S. Review.

PMID:
15041395
14.

Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation.

Formica RN Jr, Lorber KM, Friedman AL, Bia MJ, Lakkis F, Smith JD, Lorber MI.

Transplant Proc. 2003 May;35(3 Suppl):95S-98S.

PMID:
12742475
15.

Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate.

Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ.

Am J Transplant. 2002 Jan;2(1):62-7.

16.

The evolving role of tor inhibitors for individualizing posttransplant immunosuppression.

Lorber MI, Basadonna GP, Friedman AL, Lorber KM, Bia MJ, Formica R, Smith JD.

Transplant Proc. 2001 Nov-Dec;33(7-8):3075-7. No abstract available.

PMID:
11750322
17.

Parameters of high bone-turnover predict bone loss in renal transplant patients: a longitudinal study.

Cruz DN, Wysolmerski JJ, Brickel HM, Gundberg CG, Simpson CA, Mitnick MA, Kliger AS, Lorber MI, Basadonna GP, Friedman AL, Insogna KL, Bia MJ.

Transplantation. 2001 Jul 15;72(1):83-8.

PMID:
11468539
18.

Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life.

Cruz DN, Shaer AJ, Bia MJ, Lifton RP, Simon DB; Yale Gitelman's and Bartter's Syndrome Collaborative Study Group.

Kidney Int. 2001 Feb;59(2):710-7.

19.

ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients.

Abu-Alfa AK, Cruz D, Perazella MA, Mahnensmith RL, Simon D, Bia MJ.

Am J Kidney Dis. 2000 Jun;35(6):1076-82.

PMID:
10845820
20.

Geriatric issues in renal transplantation.

Bia MJ.

Geriatr Nephrol Urol. 1999;9(2):109-13. Review.

PMID:
10518254
21.

Physician Assisted Living: medical educators' perspectives.

Burrow GN, Bia MJ.

Conn Med. 1997 Dec;61(12):795. No abstract available.

PMID:
9465466
22.

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.

Darenkov IA, Marcarelli MA, Basadonna GP, Friedman AL, Lorber KM, Howe JG, Crouch J, Bia MJ, Kliger AS, Lorber MI.

Transplantation. 1997 Sep 27;64(6):848-52.

PMID:
9326409
23.

Body size mismatch between donor and recipient and the development of chronic rejection in renal transplantation.

Lee LS, Auersvald LA, Claus EB, Bia MJ, Friedman AL, Lorber MI, Basadonna GP.

Transplant Proc. 1997 Feb-Mar;29(1-2):111. No abstract available.

PMID:
9122918
24.
25.

Must living renal donors be hospitalized overnight prior to surgery?

Friedman AL, Goker O, Dennis MJ, Basadonna GP, Wiklund RA, Kliger A, Bia MJ, Lorber MI.

Clin Transplant. 1996 Oct;10(5):444-6.

PMID:
8930459
26.

Coronary revascularization in patients on dialysis. What treatment option should we choose?

Cruz DN, Bia MJ.

ASAIO J. 1996 May-Jun;42(3):139-41. Review. No abstract available.

PMID:
8725677
27.

Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.

Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP.

Nat Genet. 1996 Jan;12(1):24-30.

PMID:
8528245
28.

Serum sialic acid, a risk factor for cardiovascular disease, improves following pancreas transplantation.

Auersvald LA, Perez RV, Lorber MI, Sturges M, Friedman AL, Bia MJ, Orias M, Wilson J, Azhderian E, Gruber J, et al.

Transplant Proc. 1995 Dec;27(6):3037. No abstract available.

PMID:
8539831
29.

Enalapril treatment of posttransplant erythrocytosis: efficacy independent of circulating erythropoietin levels.

Perazella M, McPhedran P, Kliger A, Lorber M, Levy E, Bia MJ.

Am J Kidney Dis. 1995 Sep;26(3):495-500.

PMID:
7645558
30.

Evaluation of living renal donors. The current practice of US transplant centers.

Bia MJ, Ramos EL, Danovitch GM, Gaston RS, Harmon WE, Leichtman AB, Lundin PA, Neylan J, Kasiske BL.

Transplantation. 1995 Aug 27;60(4):322-7.

PMID:
7652758
31.

The evaluation and selection of living kidney donors.

Kasiske BL, Bia MJ.

Am J Kidney Dis. 1995 Aug;26(2):387-98.

PMID:
7645548
32.

The evaluation of renal transplant candidates: clinical practice guidelines. Patient Care and Education Committee of the American Society of Transplant Physicians.

Kasiske BL, Ramos EL, Gaston RS, Bia MJ, Danovitch GM, Bowen PA, Lundin PA, Murphy KJ.

J Am Soc Nephrol. 1995 Jul;6(1):1-34. Review. No abstract available.

33.

Isolated renal mucormycosis: case report and review.

Levy E, Bia MJ.

J Am Soc Nephrol. 1995 Jun;5(12):2014-9. Review.

34.

Nonimmunologic causes of late renal graft loss.

Bia MJ.

Kidney Int. 1995 May;47(5):1470-80. No abstract available.

35.

Posttransplant Epstein-Barr virus infection is associated with elevated levels of CD19+ B lymphocytes.

Morrissey PE, Lorber KM, Marcarelli M, Bia MJ, Kliger AS, Lorber MI.

Transplantation. 1995 Feb 27;59(4):637-40. No abstract available.

PMID:
7533350
36.

Immunologic monitoring after organ transplantation: relationship between Epstein-Barr virus infection and CD19+ B cells measured by flow cytometry.

Morrissey PE, Lorber KM, Marcarelli M, Bia MJ, Kliger AS, Lorber MI.

Transplant Proc. 1995 Feb;27(1):1428-30. No abstract available.

PMID:
7533384
37.

Posttransplant erythrocytosis: case report and review of newer treatment modalities.

Perazella MA, Bia MJ.

J Am Soc Nephrol. 1993 Apr;3(10):1653-9. Review.

38.

Are calcium channel blockers protective against first-dose reactions to OKT3?

Richard EA, Lorber MI, Marks WH, Bia MJ.

Transplantation. 1992 Aug;54(2):372-4. No abstract available.

PMID:
1496548
39.

Treatment of sarcoidosis-associated hypercalcemia with ketoconazole.

Bia MJ, Insogna K.

Am J Kidney Dis. 1991 Dec;18(6):702-5.

PMID:
1962657
40.

Pseudohypoaldosteronism: case report and discussion of the syndrome.

Throckmorton DC, Bia MJ.

Yale J Biol Med. 1991 May-Jun;64(3):247-54.

41.

Effects of calcium channel blockers on potassium homeostasis.

Freed MI, Rastegar A, Bia MJ.

Yale J Biol Med. 1991 Mar-Apr;64(2):177-86. Review.

42.
43.

Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy.

Meric F, Yap P, Bia MJ.

Am J Kidney Dis. 1990 Nov;16(5):459-64.

PMID:
2239937
44.

Adrenergic modulation of potassium metabolism in uremia.

Castellino P, Bia MJ, DeFronzo RA.

Kidney Int. 1990 Feb;37(2):793-8.

45.

Idiopathic Fanconi syndrome with progressive renal failure: a case report and discussion.

Long WS, Seashore MR, Siegel NJ, Bia MJ.

Yale J Biol Med. 1990 Jan-Feb;63(1):15-28.

46.

Aluminum induced anemia: pathogenesis and treatment in patients on chronic hemodialysis.

Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, Solomon L.

Kidney Int. 1989 Nov;36(5):852-8.

47.

Effects of H2-receptor antagonists on renal function in cyclosporine-treated renal transplant patients.

Pachon J, Lorber MI, Bia MJ.

Transplantation. 1989 Feb;47(2):254-9.

PMID:
2645708
48.

Unusual causes of increased vascular impedance in renal transplants: duplex Doppler evaluation.

Warshauer DM, Taylor KJ, Bia MJ, Marks WH, Weltin GG, Rigsby CM, True LD, Lorber MI.

Radiology. 1988 Nov;169(2):367-70.

PMID:
3051113
49.

Microalbuminuria and hypertension in long-term renal donors.

Watnick TJ, Jenkins RR, Rackoff P, Baumgarten A, Bia MJ.

Transplantation. 1988 Jan;45(1):59-65.

PMID:
3276064
50.

Donor-specific transfusions before transplantation. A comparison of results in children and adults at the same institutions.

Bove S, Gaudio K, Siegel N, Bia MJ.

Transplantation. 1988 Jan;45(1):224-5. No abstract available.

PMID:
3276050

Supplemental Content

Support Center